» Articles » PMID: 10531264

Laccase Protects Cryptococcus Neoformans from Antifungal Activity of Alveolar Macrophages

Overview
Journal Infect Immun
Date 1999 Oct 26
PMID 10531264
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

While laccase of Cryptococcus neoformans is implicated in the virulence of the organism, our recent studies showing absence of melanin in the infected mouse brain has led us to a search for alternative roles for laccase in cryptococcosis. We investigated the role of laccase in protection of C. neoformans against murine alveolar macrophage (AM)-mediated antifungal activity by using a pair of congenic laccase-positive (2E-TUC) and laccase-deficient (2E-TU) strains. The laccase-positive cells with laccase derepression were more resistant to the antifungal activity of AM than a laccase-deficient strain ([28.9 +/- 1.2]% versus [40.2 +/- 2.6]% killing). Addition of L-dopa to Cryptococcus to produce melanin in a laccase-positive strain resulted in a slight increase in protection of C. neoformans from the antifungal activity of macrophages ([25.4 +/- 3.4]% versus [28.9 +/- 1.2]% killing). Recombinant cryptococcal laccase exhibited iron oxidase activity in converting Fe(II) to Fe(III). Moreover, recombinant laccase inhibited killing of C. neoformans by hydroxyl radicals catalyzed by iron in a cell-free system. Addition of the hydroxyl radical scavenger mannitol or dimethyl sulfoxide to AMs prior to the introduction of cryptococcal cells decreased killing of both strains and reduced the difference in susceptibility between the laccase-positive and laccase-deficient strains. Furthermore, laccase-mediated protection from AM killing was inhibited by the addition of Fe(II), presumably by overcoming the effects of the iron oxidase activity of cryptococcal laccase. These results suggest that the iron oxidase activity of laccase may protect C. neoformans from macrophages by oxidation of phagosomal iron to Fe(III) with a resultant decrease in hydroxyl radical formation.

Citing Articles

The Rhizophagus irregularis permease RiFTR1 functions without a ferroxidase partner for reductive iron transport.

Tamayo E, Lopez-Lorca V, Shim C, Lopez-Castillo O, Castillo A, Requena N Sci Rep. 2025; 15(1):5840.

PMID: 39966403 PMC: 11836134. DOI: 10.1038/s41598-025-88416-3.


Measuring Laccase Activity and Melanin Production in Cryptococcus neoformans.

Albuquerque P, de Sousa H, de Oliveira Frazao S, do Nascimento Miranda L, Paes H, Pereira I Methods Mol Biol. 2024; 2775:257-268.

PMID: 38758323 DOI: 10.1007/978-1-0716-3722-7_17.


Fungal Laccases: Fundamentals, Engineering and Classification Update.

Aza P, Camarero S Biomolecules. 2023; 13(12).

PMID: 38136587 PMC: 10741624. DOI: 10.3390/biom13121716.


"Under Pressure" - How fungi evade, exploit, and modulate cells of the innate immune system.

Lange T, Kasper L, Gresnigt M, Brunke S, Hube B Semin Immunol. 2023; 66:101738.

PMID: 36878023 PMC: 10109127. DOI: 10.1016/j.smim.2023.101738.


Multicopper oxidases with laccase-ferroxidase activity: Classification and study of ferroxidase activity determinants in a member from .

Aza P, Molpeceres G, Vind J, Camarero S Comput Struct Biotechnol J. 2023; 21:1041-1053.

PMID: 36733701 PMC: 9880977. DOI: 10.1016/j.csbj.2023.01.030.


References
1.
Blasi E, Barluzzi R, Mazzolla R, Tancini B, Saleppico S, Puliti M . Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J Neuroimmunol. 1995; 58(1):111-6. DOI: 10.1016/0165-5728(95)00016-u. View

2.
Kwon-Chung K, Polacheck I, Popkin T . Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol. 1982; 150(3):1414-21. PMC: 216368. DOI: 10.1128/jb.150.3.1414-1421.1982. View

3.
Lovchik J, Lyons C, Lipscomb M . A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am J Respir Cell Mol Biol. 1995; 13(1):116-24. DOI: 10.1165/ajrcmb.13.1.7598935. View

4.
Wang Y, Aisen P, Casadevall A . Cryptococcus neoformans melanin and virulence: mechanism of action. Infect Immun. 1995; 63(8):3131-6. PMC: 173427. DOI: 10.1128/iai.63.8.3131-3136.1995. View

5.
Pinner R, Hajjeh R, Powderly W . Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. Clin Infect Dis. 1995; 21 Suppl 1:S103-7. DOI: 10.1093/clinids/21.supplement_1.s103. View